Literature DB >> 15034507

Facial psoriasis: comparison of patients with and without facial involvement.

Je Young Park1, Jong Hyun Rim, Yong Beom Choe, Jai Il Youn.   

Abstract

BACKGROUND: Facial involvement in psoriasis has received little attention in standard descriptions of the disease because the face has long been thought of as rarely involved. A few reports have suggested that facial involvement might be a sign of severe psoriasis. However, there have been no comparison studies on the severity of psoriasis between patients with and without facial involvement.
OBJECTIVE: We sought to evaluate the prevalence and characteristics of facial involvement, and to compare the severity of psoriasis between the patients with and without facial psoriasis.
METHODS: A total of 282 consecutive patients with psoriasis seen in our psoriasis clinic between May 2002 and November 2002 were enrolled in this study.
RESULTS: Facial involvement was a marker of severe psoriasis. The face was often involved for patients with long duration or early onset of disease; with nail or joint involvement; and those requiring more extensive treatments. Patients with facial involvement were found to have more frequent pruritus, positive family history, and history of Koebner response.
CONCLUSION: Early recognition of facial psoriasis as a marker of severe disease can contribute to treatment of patients with psoriasis.

Entities:  

Mesh:

Year:  2004        PMID: 15034507     DOI: 10.1016/s0190-9622(03)02793-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Relation between the Peripherofacial Psoriasis and Scalp Psoriasis.

Authors:  Kyung Ho Kim; Ji Young Ahn; Mi Youn Park; Jai Il Youn
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

Review 2.  Digestive system in psoriasis: an update.

Authors:  Daniel Pietrzak; Aldona Pietrzak; Dorota Krasowska; Andrzej Borzęcki; Kinga Franciszkiewicz-Pietrzak; Beata Polkowska-Pruszyńska; Maja Baranowska; Kristian Reich
Journal:  Arch Dermatol Res       Date:  2017-09-13       Impact factor: 3.017

Review 3.  Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.

Authors:  Joseph F Merola; Abrar Qureshi; M Elaine Husni
Journal:  Dermatol Ther       Date:  2018-03-06       Impact factor: 2.851

4.  Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea.

Authors:  Sang Wook Son; Dae Young Yu; Youngdoe Kim; Hyo Hyun Ahn; Yong Hyun Jang; Joo Young Roh; Young Bok Lee; Ji Yeoun Lee; Myung Hwa Kim; YoungJa Lee; Gyeong-Hun Park; Hyun-Sun Yoon; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

5.  Psoriatic Lesions Following Botulinum Toxin: A Injections to the Glabellar Region.

Authors:  Candemir Ceran; Ersin Aksam; Duriye Deniz Demirseren; Mustafa Erol Demirseren
Journal:  J Cutan Aesthet Surg       Date:  2015 Jul-Sep

6.  Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.

Authors:  Leon Kircik; Joseph Fowler; Jonathan Weiss; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.